Biomedical subjects

H Hoerauf

Publications and source records attributed to H Hoerauf.

7 recordsLinked to original sources

PubMed1997

Autosomal dominant vitreoretinochoroidopathy.

BACKGROUND: Autosomal dominant vitreoretinochoroidopathy recently has been described as a condition characterized by peripheral chorioretinal atrophy and areas of hypopigmentation and hyperpigmentation between the equator and the ora serrata circumferentially in the ocular fundus. We describe the clinical features of a family, some members of which have this disorder. This is the first such report of a family outside the United States. METHODS: We examined a family of 15 individuals, seven of whom were affected. RESULTS: The main clinical findings were peripheral pigmentary changes for 360 degrees, with a discrete boundary near the equator. In one patient, a partial vitreous detachment was found that was creating increasing traction to the macula and to the peripheral retina. Vitreous surgery successfully relieved the traction, and vision recovered from 20/100 to 20/25. One patient lost visual acuity at the age of 10 years when complete rhegmatogenous detachment occurred. In two women, a horizontal nystagmus was present showing typical signs of a congenital nystagmus. Results of electrooculography demonstrated a marked reduction of light rise and a clear reduced Arden ratio in one patient. CONCLUSIONS: Autosomal dominant vitreoretinochoroidopathy appears clinically as mainly a peripheral tapetoretinal disease; patients with this disease have been reported in and outside the United States. In addition to the typical peripheral features, significant vitreous traction maculopathy and congenital nystagmus associated with the disease were found.

Adult↗

PubMed1996

[Cyclophotocoagulation with the diode laser in contact procedure with a new focussing tip].

UNLABELLED: During contact cyclophotocoagulation (CPC) energy is transmitted through the conjunctiva and the sclera by direct contact of a plain fibre tip. Alteration and scarring of the conjunctiva and the outer parts of the sclera cannot always be avoided. We used a new fibre tip which defocuses the laser light on the conjunctiva and sclera and focuses the laser light on the ciliar body. The coupling and focusing medium between fibre and sclera is a small glass ball (3 mm diameter). METHODS: Up to now we have treated 52 human eyes of 35 patients affected by refractory glaucoma using a diode laser (Zeiss Visulas II) coupled with a 200-microns fibre and a 3-mm focusing ball tip. In all cases 20-40 spots were applied 1.5 mm posterior of the limbus, power varied between 1.5 and 2.2 W and exposure time was 1.5 s. RESULTS: In all cases the conjunctiva and the sclera was unaltered. The mean follow-up time was 224 days. The mean IOP values +/- SD before treatment and 6 days, 4 weeks and 1 year after treatment were 40.9 +/- 7.1, 19.3 +/- 7.9, 22.4 +/- 14.8 and 17.2 +/- 11.3 mmHg. No positive, linear correlation was found between number of spots and IOP drop after 6 days. There was considerable individual variance. The main complications were anterior fibrinous uveitis (10%), slight vitreous haemorrhage (2/52) and transitory hypotony (2/52). In one enucleated eye structural alterations to the pigmented and non-pigmented epithelial cells of the ciliary body were found histologically. CONCLUSIONS: Contact diode CPC can significantly reduce IOP, and the conjunctiva and sclera can be left totally unaltered by the focusing ball tip used in this study.

Aged↗

PubMed1996

[Follow-up of vitrectomy for central retinal detachment and optic disk pit].

BACKGROUND: The exact pathogenesis of central retinal detachment associated with optic disc pit is still unknown. Vitrectomy has proven to be the most effective therapy. PATIENTS AND METHODS: In two patients with macular detachment associated with optic disc pit, a pars-plana-vitrectomy with surgical posterior vitreous detachment and gastamponade was performed. We report on the interesting clinical course of these patients. RESULTS: After the gas bubble was absorbed, we observed a displacement of the subretinal fluid inferiorly in both patients. Schisislike changes persisted in the macular area. After several months the subretinal fluid resolved completely. CONCLUSION: The fluid displacement and the resolution-characteristics of the subretinal fluid after vitrectomy in cases of retinal detachment associated with optic disc pit are completely different from other rhegmatogenous retinal detachments. The gas bubble separates the central retinoschisis from the peripheral rhegmatogenous part. The reason for delayed resolution remains unclear. It may be due to tangential vitreous traction in the periphery.

Adult↗

PubMed1995

[Endotamponade with silicon oil in severe proliferative retinopathy with attached retina].

Silicone oil as endotamponade in cases with attached retina is only indicated in a few very selected cases. These are cases with a high risk of intravitreal hemorrhage and a need for quick visual rehabilitation. We examined 23 patients, who had undergone pars plana vitrectomy and silicone oil filling. All patients were diabetics with proliferative retinopathy and recurrent intravitreal hemorrhage. In 14 cases it was the only eye; 11 eyes previously had a vitrectomy. We analyzed these cases for visual acuity, rubeosis, bleeding tendency, reproliferations, cataract development and glaucoma. The follow-up time was 32 months. In 22 of 23 eyes quick visual rehabilitation was achieved, and the patients had at least ambulatory vision within the first week. In one case poor visual acuity was due to exudative maculopathy. No relevant bleeding occurred. In 14 of 16 phacic patients we observed a cataract. Seven patients developed glaucoma, which was due to neovascularization in 5 cases. It was successfully treated in all cases and no visual loss occurred. In 5 cases we observed a peripheral traction retinal detachment, in one case a traction retinal detachment at the posterior pole. In selected cases silicone oil can prevent recurrent intravitreal hemorrhage, allowing rapid visual recovery. Considering the complications, the silicone oil should be removed as soon as possible.

Diabetic Retinopathy↗

PubMed1994

[Punctate inner choroidopathy].

BACKGROUND Punctate inner choroidopathy is a rare disease, which involves the outer retina and inner choroid. The ethiology is still unknown. PATIENT The case of a 23-year-old female patient, who noticed a central scotoma on the right eye, is presented. A mild decreased visual acuity of 0.7 was noted and on ophthalmoscopy multiple, yellowish dots on the level of RPE and choroid near the fovea were found. Angiography showed a hyperfluorescence of the dots in the early phase and marked leakage in the late phase. TREATMENT Under systemic treatment with corticosteroids the acuity and the fundus changes improved. Two weeks after corticosteroidtherapy was finished, a new onset with massive exsudation occurred accompanied by a sudden decrease in vision in her right eye to 0.1. On the last examination a parafoveal suretinal scar was discovered. CONCLUSION Punctate inner choroidopathy recurrences are common. However secondary neovascular membranes are described, in general the visual outcome is good.

Adult↗

PubMed1994

[Proliferative retinopathy in chronic myeloid leukemia].

BACKGROUND: In 50% of patients with acute and chronic myelocytic leukemia retinal alterations occur which are similar to those of nonproliferative diabetic retinopathy or hypertensive retinopathy. Retinal neovascularizations, however, are rarely seen and only found in patients with the chronic disease. PATIENTS AND METHODS: We report on the clinical course of three patients with advanced stage of proliferative retinopathy in CML. In two patients, the diagnosis of CML was established after ocular involvement. Therapy was planned according to the principles, which have proven effective in other vasoproliferative retinopathies. Eyes with neovascular changes were only treated by panretinal scatter photocoagulation of the avascular zones. In the cases with complications like vitreous hemorrhage and traction retinal detachment, vitreoretinal surgery was performed. RESULTS: Using this therapeutic principles in 4 of 6 eyes a visual acuity > 0.7 could be preserved. In three eyes impending macular involvement by traction retinal detachment was prevented. CONCLUSION: The therapeutic approach, which is valid for proliferative retinopathies of various etiology is also beneficial for ocular complications in CML.

Adult↗

PubMed1994

[Photodynamic therapy of eyelid basalioma after topical administration of delta-aminolevulinic acid].

Delta-aminolevulinic acid (ALA) induced Protoporphyring IX photodynamic therapy (PDT) is a new method in the therapy of cutaneous malignancies. Topical application prevents photosensibilization of normal skin. Promising results in the treatment of superficial basal cell carcinomas have been reported. To evaluate the efficiency of this method in the therapy of basal cell carcinomas of the lid, 10 patients were treated by PDT 5 h after application of ALA. The lesions were irradiated by an argon-ion-laser-pumped dye laser at a wavelength of 630 or 635 nm and at cumulative radiant exposures of 50 and 100 J/cm2. After 5-8 weeks follow-up, the basal cell carcinomas were excised to assess histologic changes. In the first few days after PDT the lesions seemed clinically to regress, due to erythematous swelling, but after a few weeks all tumours showed the same configuration they had before irradiation. Histological examination revealed small areas of necrotic cells in all irradiated basal cell carcinomas, surrounded by residual tumour formations. The reason for the poor results may be limited penetration of ALA or light. Although ALA-induced Protoporphyrin-IX PDT is a promising approach in the therapy of dermal lesions, it is not yet an acceptable alternative method in the treatment of basal cell carcinomas of the lid.

Administration, Topical↗